Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,929 public trials 1,510 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Recruiting

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

NCT05533697

Conditions
Advanced Solid Tumors, Disease Attributes, Neoplasm Metastasis, +5 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • George Washington University Washington D.C., District of Columbia, United States
View all 39 locations
View Trial Details
Recruiting

Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting

NCT03342144

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations
  • Universitaetsklinikum St. Poelten /ID# 221152 Sankt Pölten, Lower Austria, Austria
  • Medizinische Universitaet Graz /ID# 221155 Graz, Styria, Austria
  • Landeskrankenhaus Salzburg-Universitaetsklinikum der PMU (LKH) /ID# 221153 Salzburg, Austria
  • Hanusch Krankenhaus /ID# 221151 Vienna, Austria
View all 70 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

NCT05650632

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Arizona /ID# 251405 Phoenix, Arizona, United States
  • Highlands Oncology Group - Springdale /ID# 267742 Springdale, Arkansas, United States
  • Rocky Mountain Cancer Centers - Aurora /ID# 268574 Aurora, Colorado, United States
  • Medical Oncology Hematology Consultants /ID# 268560 Newark, Delaware, United States
View all 46 locations
View Trial Details
Recruiting

A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)

NCT07302347

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
Locations
  • Nagoya City University Hospital ( Site 0003) Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital ( Site 0007) Nagoya, Aichi-ken, Japan
  • Sapporo Hokuyu Hospital ( Site 0005) Sapporo, Hokkaido, Japan
  • Hyogo Prefectural Kobe Children's Hospital ( Site 0006) Kobe, Hyōgo, Japan
View Trial Details
Recruiting

Met Non Small Cell Cancer Registry (MOMENT)

NCT05376891

Conditions
Cancer, Neoplasms
Locations
  • Holy Cross Health Fort Lauderdale, Florida, United States
  • The Ohio State University Wexner Medical Center Columbus, Ohio, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • Klinikum Klagenfurt Am Woerthersee Klagenfurt, Austria
View all 66 locations
View Trial Details
Recruiting

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

NCT05852717

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Karmanos Cancer Center (Wayne State University) Detroit, Michigan, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • University of Virginia Health System Charlottesville, Virginia, United States
View Trial Details

Related conditions